Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-35096
Stieger, B (2010). Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metabolism Reviews, 42(3):437-445.
View at publisher
Generation of bile is a key function of the liver. Its impairment leads to accumulation of cytotoxic bile salts in hepatocytes and, consequently, to liver disease. The bile salt export pump, BSEP, is critically involved in the secretion of bile salts into bile. Its function can be disturbed or abolished by inherited mutations. This will lead to progressive intrahepatic cholestais and severe liver disease. In addition to mutations, BSEP can be inhibited by acquired factors, such as xenobiotics or drugs, aberrant bile salt metabolites, or pregnancy. This inhibition will lead to acquired cholestasis. Some drugs are now known to be competitive inhibitors of Bsep. In addition, a polymorphism in the gene coding for BSEP has been identified as a potential susceptibility factor for acquired cholestasis.
134 downloads since deposited on 19 Jul 2010
19 downloads since 12 months
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology|
|Dewey Decimal Classification:||610 Medicine & health|
|Deposited On:||19 Jul 2010 08:45|
|Last Modified:||28 Nov 2013 02:10|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page